-
1
-
-
0031947875
-
Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099
-
M. Al-Sarraf, M. LeBlanc, and P.G. Giri Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized Intergroup study 0099 J Clin Oncol 16 1998 1310 1317 (Pubitemid 28175745)
-
(1998)
Journal of Clinical Oncology
, vol.16
, Issue.4
, pp. 1310-1317
-
-
Al-Sarraf, M.1
LeBlanc, M.2
Giri, P.G.S.3
Fu, K.K.4
Cooper, J.5
Vuong, T.6
Forastiere, A.A.7
Adams, G.8
Sakr, W.A.9
Schuller, D.E.10
Ensley, J.F.11
-
2
-
-
0037441720
-
Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival
-
J.C. Lin, J.S. Jan, and C.Y. Hsu Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: Positive effect on overall and progression-free survival J Clin Oncol 21 2003 631 637
-
(2003)
J Clin Oncol
, vol.21
, pp. 631-637
-
-
Lin, J.C.1
Jan, J.S.2
Hsu, C.Y.3
-
3
-
-
27244452301
-
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety
-
DOI 10.1200/JCO.2005.16.790
-
J. Wee, E.H. Tan, and B.C. Tai Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer/International Union Against Cancer stage III and IV nasopharyngeal cancer of the endemic variety J Clin Oncol 23 2005 6730 6738 (Pubitemid 46190268)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.27
, pp. 6730-6738
-
-
Wee, J.1
Tan, E.H.2
Tai, B.C.3
Wong, H.B.4
Leong, S.S.5
Tan, T.6
Chua, E.T.7
Yang, E.8
Lee, K.M.9
Fong, K.W.10
Tan, H.S.K.11
Lee, K.S.12
Loong, S.13
Sethi, V.14
Chua, E.J.15
Machin, D.16
-
4
-
-
33845361135
-
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
-
DOI 10.1093/annonc/mdl300, Special Issue: Gender and the Politics of Scale
-
P. Ceppi, M. Volante, and S. Novello ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine Ann Oncol 17 2006 1818 1825 (Pubitemid 44884058)
-
(2006)
Annals of Oncology
, vol.17
, Issue.12
, pp. 1818-1825
-
-
Ceppi, P.1
Volante, M.2
Novello, S.3
Rapa, I.4
Danenberg, K.D.5
Danenberg, P.V.6
Cambieri, A.7
Selvaggi, G.8
Saviozzi, S.9
Calogero, R.10
Papotti, M.11
Scagliotti, G.V.12
-
5
-
-
0037444279
-
Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines
-
M. Selvakumaran, D.A. Pisarcik, and R. Bao Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines Cancer Res 63 2003 1311 1316 (Pubitemid 36348710)
-
(2003)
Cancer Research
, vol.63
, Issue.6
, pp. 1311-1316
-
-
Selvakumaran, M.1
Pisarcik, D.A.2
Bao, R.3
Yeung, A.T.4
Hamilton, T.C.5
-
6
-
-
0035988959
-
Low ERRC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer
-
R.V. Lord, J. Brabender, and D. Gandara Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer Clin Cancer Res 8 2002 2286 2291 (Pubitemid 34753602)
-
(2002)
Clinical Cancer Research
, vol.8
, Issue.7
, pp. 2286-2291
-
-
Lord, R.V.N.1
Brabender, J.2
Gandara, D.3
Alberola, V.4
Camps, C.5
Domine, M.6
Cardenal, F.7
Sanchez, J.M.8
Gumerlock, P.H.9
Taron, M.10
Sanchez, J.J.11
Danenberg, K.D.12
Danenberg, P.V.13
Rosell, R.14
-
7
-
-
0033797293
-
ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells
-
R.A. Britten, D. Liu, and A. Tessier ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells Int J Cancer 89 2000 453 457
-
(2000)
Int J Cancer
, vol.89
, pp. 453-457
-
-
Britten, R.A.1
Liu, D.2
Tessier, A.3
-
8
-
-
33748435058
-
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
-
DOI 10.1056/NEJMoa060570
-
K.A. Olaussen, A. Dunant, and P. Fouret DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 2006 983 991 (Pubitemid 44343542)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.10
, pp. 983-991
-
-
Olaussen, K.A.1
Dunant, A.2
Fouret, P.3
Brambilla, E.4
Andre, F.5
Haddad, V.6
Taranchon, E.7
Filipits, M.8
Pirker, R.9
Popper, H.H.10
Stahel, R.11
Sabatier, L.12
Pignon, J.-P.13
Tursz, T.14
Le Chevalier, T.15
Soria, J.-C.16
-
9
-
-
0028018885
-
Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage
-
F. Larminat, and V.A. Bohr Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage Nucleic Acids Res 22 1994 3005 3010 (Pubitemid 24260628)
-
(1994)
Nucleic Acids Research
, vol.22
, Issue.15
, pp. 3005-3010
-
-
Larminat, F.1
Bohr, V.A.2
-
10
-
-
21244460339
-
Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis
-
DOI 10.1667/RR3401
-
W.F. Guo, R.X. Lin, and J. Huang Identification of differentially expressed genes contributing to radioresistance in lung cancer cells using microarray analysis Radiat Res 164 2005 27 35 (Pubitemid 40885227)
-
(2005)
Radiation Research
, vol.164
, Issue.1
, pp. 27-35
-
-
Guo, W.-F.1
Lin, R.-X.2
Huang, J.3
Zhou, Z.4
Yang, J.5
Guo, G.-Z.6
Wang, S.-Q.7
-
11
-
-
33644873360
-
Temporal cDNA microarray analysis of gene expression in human hepatocellular carcinoma upon radiation exposure
-
J. Jeong, S.J. Hong, and Y.J. Ju Temporal cDNA microarray analysis of gene expression in human hepatocellular carcinoma upon radiation exposure Oncol Rep 15 2006 33 48
-
(2006)
Oncol Rep
, vol.15
, pp. 33-48
-
-
Jeong, J.1
Hong, S.J.2
Ju, Y.J.3
-
12
-
-
0030566883
-
The importance of the ERCC1/ERCC4[XPF] complex for hypoxic-cell radioresistance does not appear to derive from its participation in the nucleotide excision repair pathway
-
DOI 10.1016/S0921-8777(96)00036-5, PII S0921877796000365
-
D. Murray, and E. Rosenberg The importance of the ERCC1/ERCC4[XPF] complex for hypoxic-cell radioresistance does not appear to derive from its participation in the nucleotide excision repair pathway Mutat Res 364 1996 217 226 (Pubitemid 26408461)
-
(1996)
Mutation Research - DNA Repair
, vol.364
, Issue.3
, pp. 217-226
-
-
Murray, D.1
Rosenberg, E.2
-
13
-
-
79957576030
-
High ERCC1 expression is associated with worse survival in patients with locally advanced cervical cancer treated with radiotherapy (RT): An evaluation of AQUA? versus conventional IHC methods
-
C.M. Doll, P. Craighead, and R. Diaz High ERCC1 expression is associated with worse survival in patients with locally advanced cervical cancer treated with radiotherapy (RT): An evaluation of AQUA? versus conventional IHC methods Int J Radiat Oncol Biol Phys 72 2008 S18 S19
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
-
-
Doll, C.M.1
Craighead, P.2
Diaz, R.3
-
14
-
-
37149046306
-
ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer
-
DOI 10.1016/j.ejca.2007.09.006, PII S0959804907007320
-
M.K. Kim, K.J. Cho, and G.Y. Kwon ERCC1 predicting chemoradiation resistance and poor outcome in oesophageal cancer Eur J Cancer 44 2008 54 60 (Pubitemid 350256935)
-
(2008)
European Journal of Cancer
, vol.44
, Issue.1
, pp. 54-60
-
-
Kim, M.K.1
Cho, K.-J.2
Kwon, G.Y.3
Park, S.-I.4
Kim, Y.H.5
Kim, J.H.6
Song, H.-Y.7
Shin, J.H.8
Jung, H.Y.9
Lee, G.H.10
Choi, K.D.11
Kim, S.-B.12
-
15
-
-
17044428615
-
High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer
-
M.B. Joshi, Y. Shirota, and K.D. Danenberg High gene expression of TS1, GSTP1, and ERCC1 are risk factors for survival in patients treated with trimodality therapy for esophageal cancer Clin Cancer Res 11 2005 2215 2221
-
(2005)
Clin Cancer Res
, vol.11
, pp. 2215-2221
-
-
Joshi, M.B.1
Shirota, Y.2
Danenberg, K.D.3
-
16
-
-
33748430003
-
Expression of XRCC1 and ERCC1 proteins in radioresistant and radiosensitive laryngeal cancer
-
P. Nix, J. Greenman, and N. Stafford Expression of XRCC1 and ERCC1 proteins in radioresistant and radiosensitive laryngeal cancer Cancer Ther 2 2004 47 53
-
(2004)
Cancer Ther
, vol.2
, pp. 47-53
-
-
Nix, P.1
Greenman, J.2
Stafford, N.3
-
17
-
-
67349119484
-
Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation
-
K. Azuma, T. Sasada, and A. Kawahara Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation Cancer Chemother Pharmacol 64 2009 565 573
-
(2009)
Cancer Chemother Pharmacol
, vol.64
, pp. 565-573
-
-
Azuma, K.1
Sasada, T.2
Kawahara, A.3
-
18
-
-
53149098596
-
ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy
-
I.G. Hwang, M.J. Ahn, and B.B. Park ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy Cancer 113 2008 1379 1386
-
(2008)
Cancer
, vol.113
, pp. 1379-1386
-
-
Hwang, I.G.1
Ahn, M.J.2
Park, B.B.3
-
19
-
-
46349110628
-
ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
-
DOI 10.1038/sj.bjc.6604464, PII 6604464
-
H.J. Jun, M.J. Ahn, and H.S. Kim ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation Br J Cancer 99 2008 167 172 (Pubitemid 351920246)
-
(2008)
British Journal of Cancer
, vol.99
, Issue.1
, pp. 167-172
-
-
Jun, H.J.1
Ahn, M.J.2
Kim, H.S.3
Yi, S.Y.4
Han, J.5
Lee, S.K.6
Ahn, Y.C.7
Jeong, H.-S.8
Son, Y.-I.9
Baek, J.-H.10
Park, K.11
-
21
-
-
0037455826
-
Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): An encouraging reduction in both incidence and mortality
-
DOI 10.1002/ijc.10894
-
A.W. Lee, W. Foo, and O. Mang Changing epidemiology of nasopharyngeal carcinoma in Hong Kong over a 20-year period (1980-99): An encouraging reduction in both incidence and mortality Int J Cancer 103 2003 680 685 (Pubitemid 36091475)
-
(2003)
International Journal of Cancer
, vol.103
, Issue.5
, pp. 680-685
-
-
Lee, A.W.M.1
Foo, W.2
Mang, O.3
Sze, W.M.4
Chappell, R.5
Lau, W.H.6
Ko, W.M.7
-
23
-
-
0032147260
-
The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma
-
DOI 10.1002/(SICI)1097-0142(19980801)83:3<582::AID-CNCR29>3.0.CO;2- R
-
J.E. Marks, J.L. Phillips, and H.R. Menck The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma Cancer 83 1998 582 588 (Pubitemid 28354516)
-
(1998)
Cancer
, vol.83
, Issue.3
, pp. 582-588
-
-
Marks, J.E.1
Phillips, J.L.2
Menck, H.R.3
-
24
-
-
0028918208
-
Prognostic significance of keratinization in nasopharyngeal carcinoma
-
S.P. Reddy, W.F. Raslan, and S. Gooneratne Prognostic significance of keratinization in nasopharyngeal carcinoma Am J Otolaryngol 16 1995 103 108
-
(1995)
Am J Otolaryngol
, vol.16
, pp. 103-108
-
-
Reddy, S.P.1
Raslan, W.F.2
Gooneratne, S.3
-
25
-
-
0023866398
-
Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation
-
D.X. Qin, Y.H. Hu, and J.H. Yan Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation Cancer 61 1988 1117 1124
-
(1988)
Cancer
, vol.61
, pp. 1117-1124
-
-
Qin, D.X.1
Hu, Y.H.2
Yan, J.H.3
-
26
-
-
0024538507
-
Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1302 patients
-
E.P. Zhang, P.G. Lian, and K.L. Cai Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1302 patients Int J Radiat Oncol Biol Phys 16 1989 301 305
-
(1989)
Int J Radiat Oncol Biol Phys
, vol.16
, pp. 301-305
-
-
Zhang, E.P.1
Lian, P.G.2
Cai, K.L.3
-
27
-
-
15944417086
-
Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
-
DOI 10.1093/jnci/dji084
-
A.T. Chan, S.F. Leung, and R.K. Ngan Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma J Natl Cancer Inst 97 2005 536 539 (Pubitemid 40590436)
-
(2005)
Journal of the National Cancer Institute
, vol.97
, Issue.7
, pp. 536-539
-
-
Chan, A.T.C.1
Leung, S.F.2
Ngan, R.K.C.3
Teo, P.M.L.4
Lau, W.H.5
Kwan, W.H.6
Hui, E.P.7
Yiu, H.Y.8
Yeo, W.9
Cheung, F.Y.10
Yu, K.H.11
Chiu, K.W.12
Chan, D.T.13
Mok, T.S.K.14
Yau, S.15
Yuen, K.T.16
Mo, F.K.F.17
Lai, M.M.P.18
Ma, B.B.Y.19
Kam, M.K.M.20
Leung, T.W.T.21
Johnson, P.J.22
Choi, P.H.K.23
Zee, B.C.Y.24
more..
-
28
-
-
4344709667
-
Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: A factorial study
-
DOI 10.1200/JCO.2004.05.173
-
D.L. Kwong, J.S. Sham, and G.K. Au Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: A factorial study J Clin Oncol 22 2004 2643 2653 (Pubitemid 41103752)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.13
, pp. 2643-2653
-
-
Kwong, D.L.W.1
Sham, J.S.T.2
Au, G.K.H.3
Chua, D.T.T.4
Kwong, P.W.K.5
Cheng, A.C.K.6
Wu, P.M.7
Law, M.W.M.8
Kwok, C.C.H.9
Yau, C.C.10
Wan, K.Y.11
Chan, R.T.T.12
Choy, D.D.K.13
-
29
-
-
67349275022
-
Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel
-
K. Azuma, T. Sasada, and A. Kawahara Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel Lung Cancer 64 2009 326 333
-
(2009)
Lung Cancer
, vol.64
, pp. 326-333
-
-
Azuma, K.1
Sasada, T.2
Kawahara, A.3
-
30
-
-
0037032506
-
Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma
-
A.T. Chan, Y.M. Lo, and B. Zee Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma J Natl Cancer Inst 94 2002 1614 1619 (Pubitemid 35378726)
-
(2002)
Journal of the National Cancer Institute
, vol.94
, Issue.21
, pp. 1614-1619
-
-
Chan, A.T.C.1
Lo, Y.M.D.2
Zee, B.3
Chan, L.Y.S.4
Ma, B.B.Y.5
Leung, S.-F.6
Mo, F.7
Lai, M.8
Ho, S.9
Huang, D.P.10
Johnson, P.J.11
-
31
-
-
2942607684
-
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma
-
DOI 10.1056/NEJMoa032260
-
J.C. Lin, W.Y. Wang, and K.Y. Chen Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma N Engl J Med 350 2004 2461 2470 (Pubitemid 38736543)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.24
, pp. 2461-2470
-
-
Lin, J.-C.1
Wang, W.-Y.2
Chen, K.Y.3
Wei, Y.-H.4
Liang, W.-M.5
Jan, J.-S.6
Jiang, R.-S.7
-
32
-
-
33646432731
-
Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area
-
J.S. Kalpoe, P.B. Dekker, and J.H. van Krieken Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area J Clin Pathol 59 2006 537 541
-
(2006)
J Clin Pathol
, vol.59
, pp. 537-541
-
-
Kalpoe, J.S.1
Dekker, P.B.2
Van Krieken, J.H.3
-
33
-
-
79957574805
-
Association of Epstein-Barr virus and head and neck cancer in an endemic area
-
A.Y. Kim, J.L. Roh, and J.M. Kim Association of Epstein-Barr virus and head and neck cancer in an endemic area Korean J Otolaryngol Head Neck Surg 50 2007 235 239
-
(2007)
Korean J Otolaryngol Head Neck Surg
, vol.50
, pp. 235-239
-
-
Kim, A.Y.1
Roh, J.L.2
Kim, J.M.3
|